8-K

Company

Cardiff Oncology, Inc.

Filed

June 3, 2024

Period of Report

May 30, 2024

Accession Number

0001628280-24-026295

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →